Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
暂无分享,去创建一个
I. Pavord | G. Collins | H. Pass | N. Maskell | N. Rahman | H. Schiller | R. Fischer | S. Gerry | B. Kessler | R. Hallifax | N. Kanellakis | G. Stathopoulos | I. Psallidas | R. Mercer | R. Asciak | M. Thézénas | T. Dong | M. Dobson | A. Samsonova | C. Phil
[1] N. Rahman,et al. Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial , 2017, BMJ Open Respiratory Research.
[2] Lu Shi,et al. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. , 2017, Cancer Treatment Reviews.
[3] J. M. Porcel,et al. Malignant pleural effusion: from bench to bedside , 2016, European Respiratory Review.
[4] Anoop Chauhan,et al. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial. , 2015, JAMA.
[5] N. Maskell,et al. Individualised management of malignant pleural effusion. , 2015, The Lancet. Respiratory medicine.
[6] G. Collins,et al. Effect of Ebola Progression in Liberia , 2015, Annals of Internal Medicine.
[7] R. Fischer,et al. Gel-aided sample preparation (GASP)—A simplified method for gel-assisted proteomic sample generation from protein extracts and intact cells , 2015, Proteomics.
[8] Raphael Gottardo,et al. Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.
[9] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[10] Brennan C Kahan,et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score , 2014, Thorax.
[11] Huan Xia,et al. Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis , 2014, PloS one.
[12] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[13] H. Davies,et al. Management of malignant pleural effusions: questions that need answers , 2013, Current opinion in pulmonary medicine.
[14] C. Roussos,et al. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion , 2013, Oncogene.
[15] Sun-Hee Kim,et al. Expression level and glycan dynamics determine the net effects of TIMP-1 on cancer progression , 2012, BMB reports.
[16] H. Pass,et al. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. , 2012, The New England journal of medicine.
[17] R. Davies,et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. , 2012, JAMA.
[18] B. Nordestgaard,et al. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer , 2011, Critical reviews in clinical laboratory sciences.
[19] B. Davidson,et al. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions , 2010, Clinical & Experimental Metastasis.
[20] D Goldberg,et al. Critical Reviews in Clinical Laboratory Sciences , 2010, Critical reviews in clinical laboratory sciences.
[21] Chuanshu Huang,et al. Inflammation, a Key Event in Cancer Development , 2006, Molecular Cancer Research.
[22] Ralph B D'Agostino,et al. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. , 2005, Statistics in medicine.
[23] C. Luparello,et al. Tissue inhibitor of metalloprotease (TIMP)‐1 and proliferative behaviour of clonal breast cancer cells , 1999, Breast Cancer Research and Treatment.
[24] W. Stetler-Stevenson,et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. , 1998, The Journal of clinical investigation.
[25] HighWire Press. European respiratory review : an official journal of the European Respiratory Society. , 1991 .
[26] M. Tattersall,et al. Management of malignant pleural effusions. , 1990, Thorax.